|
CHIC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.24950058580475E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.09719999541858E-09 |
| Normal-vs-Stage2 |
3.966200E-04 |
| Normal-vs-Stage3 |
6.47869535796985E-11 |
| Normal-vs-Stage4 |
4.05580014017914E-10 |
| Stage1-vs-Stage2 |
3.034000E-01 |
| Stage1-vs-Stage3 |
5.565700E-02 |
| Stage1-vs-Stage4 |
1.646150E-02 |
| Stage2-vs-Stage3 |
1.975620E-02 |
| Stage2-vs-Stage4 |
4.280900E-03 |
| Stage3-vs-Stage4 |
3.457800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.07045491862345E-12 |
| Normal-vs-AfricanAmerican |
1.895600E-03 |
| Normal-vs-Asian |
1.34179999999873E-06 |
| Caucasian-vs-AfricanAmerican |
2.449800E-01 |
| Caucasian-vs-Asian |
4.119600E-01 |
| AfricanAmerican-vs-Asian |
5.947000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.70220537454702E-11 |
| Normal-vs-Female |
6.84610035328603E-10 |
| Male-vs-Female |
2.605800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.76919999550896E-08 |
| Normal-vs-Age(41-60Yrs) |
2.09819994712035E-09 |
| Normal-vs-Age(61-80Yrs) |
9.47860012701085E-10 |
| Normal-vs-Age(81-100Yrs) |
1.824000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.745200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.092400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.350000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.133000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.561000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.796800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.08220000000359E-05 |
| Classical-VS-Follicular |
1.958760E-01 |
| Classical-VS-Other |
4.582400E-01 |
| Classical-VS-Normal |
4.13060030624024E-10 |
| Tall-VS-Follicular |
4.06889999999827E-05 |
| Tall-VS-Other |
3.407400E-01 |
| Tall-VS-Normal |
1.23260290862959E-11 |
| Follicular-VS-Other |
3.042000E-01 |
| Follicular-VS-Normal |
1.621740E-04 |
| Other-VS-Normal |
6.478600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.21860016206222E-10 |
| Normal-vs-N1 |
5.48629996988126E-09 |
| N0-vs-N1 |
1.007590E-01 |
|
|
